FierceMedTech Names FineHeart as One of Its “Fierce 15” Med Tech Companies of 2018

BORDEAUX, France–(BUSINESS WIRE)–FineHeart today announced that it has been named by FierceMedTech as one of 2018’s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry. FineHeart’s technology, the ICOMS (Implantable Cardiac Output Management System), is dedicated to the treatment of severe heart […]

Kardium Announces New Financing to Commercialize the Globe System for the Treatment of Atrial Fibrillation

VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, announced today that it has raised an undisclosed amount in a new financing round. The financing was led by funds and accounts advised by T. Rowe Price Associates, Inc., and included participation from […]

LeMaitre Vascular Will Announce Fourth Quarter 2018 Earnings Results on February 19, 2019

BURLINGTON, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2018 financial results on Tuesday, February 19, 2019, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and […]

InspireMD to Report Fourth Quarter and Fiscal 2018 Financial Results and Provide Business Update on Tuesday, February 19

TEL AVIV, Israel, Feb. 07, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, February 19, […]

VentureMed Group Names J. Robert Paulson Jr. Chief Executive Officer

Toledo, Ohio, February 5, 2019 – VentureMed Group, Inc., a privately-held medical device company that develops and markets the FLEX Vessel Prep™ System to treat peripheral arterial disease (PAD) and stenoses of arteriovenous (AV) fistulas and grafts, announced today that J. Robert Paulson, Jr., has been appointed president and chief […]

Boston Scientific Announces Results For Fourth Quarter And Full Year 2018

MARLBOROUGH, Mass., Feb. 6, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.561 billion during the fourth quarter of 2018. This represents growth of 6.3 percent on a reported basis, 8.2 percent on an operational1 basis and 7.0 percent on an organic2 basis, all compared to the prior year period. The company reported […]

REVA Announces Reduction in Force

SAN DIEGO, Feb. 04, 2019 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced it is realigning the organization to align with current business conditions. Effective February 8, 2019, REVA will reduce its San Diego-based personnel to […]

BioSig Appoints John Kowalski to Lead Commercialization of PURE EP

Santa Monica, CA, Feb. 05, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the Company has appointed Mr. John Kowalski as Vice President of Sales. Mr. […]